From: Adiponectin, diabetes and ischemic heart failure: a challenging relationship
Model 1 | Model 2 | Model 3 | Model 4 | |||||
---|---|---|---|---|---|---|---|---|
R=0.62, <0.001 | R=0.63, <0.001 | R=0.63, <0.001 | R=0.69, <0.001 | |||||
B±SE | p | B±SE | p | B±SE | p | B±SE | p | |
Age | 0.24±0.05 | <0.001 | 0.17±0.05 | <0.001 | 0.10±0.05 | 0.021 | 0.07±0.04 | 0.124 |
Gender | 5.70±1.51 | <0.001 | 4.05±1.49 | 0.008 | 4.49±1.41 | 0.002 | 1.97±1.47 | 0.182 |
ACC/AHA stage | 2.47±0.60 | <0.001 | 1.77±0.62 | 0.005 | 1.38±0.60 | 0.023 | 1.40±0.57 | 0.016 |
Diabetes | −3.44±0.99 | 0.001 | −2.90±0.95 | 0.003 | −1.37±1.02 | 0.182 | −1.86±0.98 | 0.061 |
NT-proBNP | 0.01±0.01 | 0.001 | 0.01±0.01 | <0.001 | 0.01±0.01 | <0.001 | ||
BMI | −0.30±0.11 | 0.008 | −0.17±0.12 | 0.164 | ||||
HDL cholesterol | 0.17±0.04 | <0.001 |